Category: Investing

Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce important new data from our ongoing ACCENT clinical trial in pancreatic cancer. The trial is investigating the Company’s best-in-class FAK inhibitor narmafotinib in combination with standard-of-care chemotherapies gemcitabine and Abraxane. Fifteen (15) confirmed partial responses (PRs) have now been recorded in the…

Greenvale Energy (GRV:AU) has announced Multiple Uranium Anomalies Identified at Key NT Projects Download the PDF here. This post appeared first on investingnews.com

Tolu Minerals Limited (“Tolu”) is pleased to announce the granting of its Ipi River tenement EL 2780 (Figure 1) covering 395.56 km2 of highly prospective copper-gold mineralisation. The historically discovered Ipi River porphyry deposit within EL 2780, located 55 km northwest of the Tolukuma gold mine is one of several under-explored porphyry style Cu-Au-Mo systems…

Sarama Resources (SRR:AU) has announced Q1 2025 Management’s Discussion and Analysis Download the PDF here. This post appeared first on investingnews.com

Sarama Resources (SRR:AU) has announced Q1 2025 Interim Financial Statements Download the PDF here. This post appeared first on investingnews.com

Bitcoin is prone to price volatility, with wide swings to the upside and downside, making it difficult for investors to know when the right time to buy the top crypto is. There has been renewed interest in cryptocurrencies following the election of US President Donald Trump, leading the Bitcoin price to soar to new heights…

Tartana Minerals (TAT:AU) has announced Director led financing and change of Chairman Download the PDF here. This post appeared first on investingnews.com

(TheNewswire) May 13, 2025 – TheNewswire – Vancouver, British Columbia, Canada JZR Gold Inc. (TSXV:  JZR) (OTCQB: JZRIF) (the ‘ Company ‘ or ‘ JZR ‘) wishes to provide an update on operations at Vila Nova Gold Project (the ‘ Vila Nova Project ‘ or the ‘ Property ‘) located in the state of Amapa,…

DSMC concluded that Phase 1 study may continue as planned without any modifications On track to complete the enrollment of the first two cohorts by mid-2025 Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, announced today…

finlay minerals ltd. (TSXV: FYL) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’) is pleased to announce that it has appointed Robert F. Brown as Executive Chairman of the Board, and Ilona Barakso Lindsay as President & Chief Executive Officer. Mr. Brown and Ms. Lindsay formerly held the positions of President & CEO, and Vice President Corporate…